Plain-English translation of NCT07781501 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to better understand Long COVID—the ongoing symptoms some people experience months or even years after a COVID-19 infection. This study will collect health information and saliva samples from 500 adults with a history of COVID-19 to look for biological patterns that might explain why some people develop persistent symptoms and others don't. By analyzing these samples alongside your health history, scientists hope to identify risk factors and improve our ability to predict and eventually treat Long COVID.
Long COVID affects millions of people, but doctors don't yet fully understand what causes it or why it affects some people more severely than others. This research aims to close that gap by finding biological clues in saliva that might help explain persistent symptoms and guide future treatments.
You likely qualify if…
You likely don't qualify if…
You'll answer detailed questionnaires about your health, symptoms, and how COVID-19 has affected you since your infection. You'll also provide a saliva sample, which researchers will analyze for proteins, immune markers, and other biological factors linked to Long COVID. The study may involve follow-up visits or additional questionnaires over time to track how your symptoms change. Most of the process is straightforward and can often be done in a single visit or over a few weeks.
AI-generated summary from trial data · Aug 24, 2026 · Not medical advice
United States